Affiliation:
1. The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Abstract
Abstract
The majority of patients with primary or metastatic hepatic tumors are not candidates for resection because of tumor size, location near major intrahepatic blood vessels precluding a margin-negative resection, multifocality, or inadequate hepatic function related to coexistent cirrhosis. Radiofrequency ablation (RFA) is an evolving technology being used to treat patients with unresectable primary and metastatic hepatic cancers. RFA produces coagulative necrosis of tumor through local tissue heating. Liver tumors are treated percutaneously, laparoscopically, or during laparotomy using ultrasonography to identify tumors and guide placement of the RFA needle electrode. For tumors smaller than 2.0 cm in diameter, one or two deployments of the monopolar multiple array needle electrode are sufficient to produce complete coagulative necrosis of the tumor. However, with increasing size of the tumor, there is a concomitant increase in the number of deployments of the needle electrode and the overall time necessary to produce complete coagulative necrosis of the tumor. In general, RFA is a safe, well-tolerated, effective treatment for unresectable hepatic malignancies less than 6.0 cm in diameter. Effective treatment of larger tumors awaits the development of more powerful, larger array monopolar and bipolar RFA technologies.
Publisher
Oxford University Press (OUP)
Reference47 articles.
1. NIH conference on hepatocellular carcinoma;Di Bisceglie;Ann Intern Med,1988
2. Hematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies;Weiss;J Pathol,1986
3. Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment;Liver Cancer Study Group of Japan;Ann Surg,1990
4. Primary hepatic malignancy: surgical management and determinants of survival;Nagorney;Surgery,1989
5. Liver resection for colorectal metastases;Fong;J Clin Oncol,1997
Cited by
171 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献